株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の乳がん市場

Global Breast Cancer Market: Industry Analysis & Outlook 2017-2021

発行 Koncept Analytics 商品コード 204467
出版日 ページ情報 英文 70 Pages
即納可能
価格
本日の銀行送金レート: 1USD=111.90円で換算しております。
Back to Top
世界の乳がん市場 Global Breast Cancer Market: Industry Analysis & Outlook 2017-2021
出版日: 2017年02月03日 ページ情報: 英文 70 Pages
概要

乳がんは、最も頻繁に診断されるがんで、女性のがんによる死亡原因の第1位です。乳がんの最も一般的な危険因子は、女性であることと、加齢です。

当レポートでは、世界の乳がん診断・治療市場について調査分析し、米国、ブラジル、欧州、アジア太平洋地域に焦点を当てて、市場力学、成長促進要因と課題、競合情勢、主要企業などについて、体系的な情報を提供しています。

第1章 市場概要

  • 乳がん
  • 乳がんの種類
  • 危険因子
  • 乳がんの症状
  • 乳がんの診断と治療
    • 乳がんの検査・診断法
    • 乳がんの治療法

第2章 乳がん市場

  • 世界市場
    • 診断市場
    • 治療市場
    • 市場区分

第3章 地域市場

  • 米国
  • ブラジル
  • アジア太平洋地域
  • 欧州

第4章 市場力学

  • 業界の発展
  • 成長促進要因
  • 課題

第5章 競合情勢

  • 医薬品の比較
  • 純利益
  • R&D予算

第6章 企業プロファイル

  • 事業概要、財務概要、事業戦略
    • Johnson & Johnson
    • Hologic, Inc.
    • Roche
    • Novartis
    • Siemens AG

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

'Breast cancer' defines a malignant tumor that has developed from cells in the breast. Some breast cancers are called in situ as they are confined within the ducts (ductal carcinoma in situ or DCIS) or lobules (lobular carcinoma in situ or LCIS) where they originated. Although, less commonly, breast cancer can also instigate in the stromal tissues, which include the fatty and fibrous connective tissues of the breast. In the early stages, breast cancer may not cause any symptoms. A lump may be too small to feel or to cause any unusual changes that could be noticed on own. Typically, an abnormal area shows up on a screening mammogram which leads to further testing. Several risk factors including smoking and alcohol consumption, exposure to estrogen, gender, age, radiation therapy, family history and personal history are linked to the growth of breast cancer.

The global market for breast cancer has grown swiftly over the past few years driven by introduction of several new drugs and biosimilars. The overall breast cancer market remained mainly dominated by the generic drugs. The future market for breast cancer will grow in the coming years as there exist unmet need for new drugs that would overcome resistance and prevent recurrence of the disease.

The global breast cancer market is likely to grow strongly in the coming years driven by rising healthcare expenditure, rising diabetic and obese population, increased spending on medicines, increasing consumption of alcohol and tobacco and rising female population above 65 years of age. Key trends of the market includes rising development of PARP inhibitors, clinical trials of CDK4/6 inhibitors and introduction of new imaging tests. However, growth of the market can be hindered by several factors including drug development challenges in developing countries, long term side effects of drugs and heavy costs associated with drug development.

The report "Global Breast Cancer Market: Industry Analysis & Outlook (2017-2021)" by Koncept Analytics provides an extensive research and detailed analysis of the present market along with future outlook. The report discusses the major growth drivers and challenges of the market, covering the U.S., Europe and APAC regions along with the global market. The report profiles the key players of the market including Johnson & Johnson, AbbVie, AstraZeneca and Roche.

Table of Contents

1. Introduction

  • 1.1 Market Overview

2. Global Breast Cancer Market

  • 2.1 Global Breast Cancer Market by Value
  • 2.2 Global Breast Cancer Market Forecast by Value
  • 2.3 Global Breast Cancer Market by Region
  • 2.4 Global Breast Cancer Drug Development by Stages

3. Regional Breast Cancer Market

  • 3.1 The U.S.
    • 3.1.1 The U.S. Breast Cancer Market by Value
    • 3.1.2 The U.S. Breast Cancer Market Forecast by Value
    • 3.1.3 The U.S. Breast Cancer Market by Addressable Population
    • 3.1.4 The U.S. Breast Cancer Market Forecast by Addressable Population
    • 3.1.5 The U.S. Breast Cancer Population by Age
  • 3.2 Europe
    • 3.2.1 EU5 Breast Cancer Market by Value
    • 3.2.2 EU5 Breast Cancer Market Forecast by Value
  • 3.3 APAC
    • 3.3.1 APAC Breast Cancer Market by Value
    • 3.3.2 APAC Breast Cancer Market Forecast by Value
    • 3.3.3 APAC Breast Cancer Market by Countries
    • 3.3.4 Japan's Breast Cancer Market by Value
    • 3.3.5 Japan's Breast Cancer Market Forecast by Value
    • 3.3.6 China's Breast Cancer Market by Value
    • 3.3.7 China's Breast Cancer Market Forecast by Value
    • 3.3.8 Australia's Breast Cancer Market by Value
    • 3.3.9 Australia's Breast Cancer Market Forecast by Value

4. Market Dynamics

  • 4.1 Growth Drivers
    • 4.1.1 Rising Consumption of Tobacco and Alcohol
    • 4.1.2 Increasing Global Diabetic Population
    • 4.1.3 Increasing Obesity
    • 4.1.4 Increasing Healthcare Expenditure Per Capita
    • 4.1.5 Rising Female Population Aged 65 Years & Above
    • 4.1.6 Global Spending on Medicines
  • 4.2 Key Trends & Developments
    • 4.2.1 PARP Inhibitors under Development
    • 4.2.2 CDK4/6 Inhibitors Under Clinical Trials for Breast Cancer
    • 4.2.3 Introduction of Newer Imaging Tests
  • 4.3 Challenges
    • 4.3.1 Long Term Side Effects
    • 4.3.2 Drug Development Challenges in Developing Countries
    • 4.3.3 Heavy Drug Developmental Costs

5. Competition

  • 5.1 Revenue Comparison
  • 5.2 Research & Development Expenditure Comparison
  • 5.3 Market Cap Comparison

6. Company Profiles

  • 6.1 Johnson & Johnson
    • 6.1.1 Business Overview
    • 6.1.2 Financial Overview
    • 6.1.3 Business Strategies
  • 6.2 AstraZeneca
    • 6.2.1 Business Overview
    • 6.2.2 Financial Overview
    • 6.2.3 Business Strategies
  • 6.3 AbbVie
    • 6.3.1 Business Overview
    • 6.3.2 Financial Overview
    • 6.3.3 Business Strategies
  • 6.4 Roche
    • 6.4.1 Business Overview
    • 6.4.2 Financial Overview
    • 6.4.3 Business Strategies

List of Charts

  • Breast Cancer by Types
  • Stages of Breast Cancer
  • Global Breast Cancer Market by Value (2012-2016)
  • Global Breast Cancer Market Forecast by Value (2017-2021)
  • Global Breast Cancer Market by Region (2016)
  • Global Breast Cancer Drug Development by Stages (2016)
  • The U.S. Breast Cancer Market by Value (2012-2016)
  • The U.S. Breast Cancer Market Forecast by Value (2017-2021)
  • The U.S. Breast Cancer Market by Addressable Population (2012-2016)
  • The U.S. Breast Cancer Market Forecast by Addressable Population (2017-2021)
  • The U.S. Breast Cancer Population by Age & Type (2016)
  • EU5 Breast Cancer Market by Value (2012-2016)
  • EU5 Breast Cancer Market Forecast by Value (2017-2021)
  • APAC Breast Cancer Market by Value (2012-2016)
  • APAC Breast Cancer Market Forecast by Value (2017-2021)
  • APAC Breast Cancer Market by Countries (2016)
  • Japan's Breast Cancer Market by Value (2012-2016)
  • Japan's Breast Cancer Market Forecast by Value (2017-2021)
  • China's Breast Cancer Market by Value (2012-2016)
  • China's Breast Cancer Market Forecast by Value (2017-2021)
  • Australia's Breast Cancer Market by Value (2012-2016)
  • Australia's Breast Cancer Forecast Market by Value (2017-2021)
  • Global Cigarette Consumption (1990-2016E)
  • Global Diabetic Population (2012-2016E)
  • Global Obese Population (2012-2016E)
  • Global Healthcare Expenditure Per Capita (2012-2016E)
  • Global Female Population Aged 65 Years and Above (2015-2050E)
  • Global Spending on Medicines (2007-2017E)
  • Key PARP Inhibitors under Development (2016)
  • Key CDK4/6 Inhibitors Clinical Status for Breast Cancer (2016)
  • Key Players Revenue Comparison (2015)
  • Key Players R&D Expenditure (2015)
  • Key Players Market Cap Comparison (2016)
  • Johnson & Johnson Sales by Segments (2016*)
  • J&J Revenue (2010-2015)
  • AstraZeneca Product Sales by Region (2015)
  • AstraZeneca Revenue and Profit (2012-2015)
  • AstraZeneca Development Pipeline Overview
  • AbbVie Net Revenue by Product Segments (2015)
  • AbbVie Net Revenues (2011-2015)
  • Roche Sales by Segments (2015)
  • Roche Sales and Net Income (2011-2015)
Back to Top